Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
41.99Prev. Close
42.04Volume
5,715Total traded value
0.02 CrUpper Circuit
44.14Lower Circuit
39.93Fundamentals
| Market Cap | ₹68Cr |
| ROE | 2.97% |
| P/E Ratio(TTM) | 24.38 |
| EPS(TTM) | 1.72 |
| P/B Ratio | 3.63 |
| Dividend Yield | 0.00% |
| Industry P/E | 38.99 |
| Book Value | 11.54 |
| Debt to Equity | 0.03 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Biofil Chemicals And Pharmaceuticals
Biofil Chemicals and Pharmaceuticals manufactures and trades pharmaceuticals, including job work, and is a major producer of Ferrous Sulphate and Microcrystalline Cellulose Powder. The company's philosophy is that it grows when its people grow, emphasizing talent management and leadership development. For the 2023-24 financial year, the company achieved a total income of ₹4052.50 lacs, showing significant growth from the previous year.;
| Parent Organisation | Biofil Chemicals And Pharmaceuticals |
| Managing Director | Shri. Ramesh Shah |
| NSE Symbol | BIOFILCHEM |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.60 | ||
| Gland Pharma | NA (0.00%) | 43.02 | ||
| Ajanta Pharma | NA (0.00%) | 32.53 | ||
| Eris Lifesciences | NA (0.00%) | 55.50 |